What is FPMI stock price today?

FPMI (Fluoropharma Medical) stock is trading at $0.00 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is FPMI stock going up or down today?

FPMI stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy FPMI stock now?

The decision to buy FPMI depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is FPMI a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for FPMI based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is FPMI stock overvalued or undervalued?

Use our DCF valuation calculator to determine if FPMI is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is FPMI's P/E ratio?

P/E ratio data for FPMI will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is FPMI's market cap?

FPMI (Fluoropharma Medical) has a market capitalization of $0.00 billion, making it a small-cap stock.

What is FPMI's price to book ratio?

FPMI trades at a price-to-book (P/B) ratio of 17.76, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does FPMI pay dividends?

FPMI does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is FPMI's dividend yield?

FPMI does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is FPMI stock a good long-term investment?

FPMI's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is FPMI's revenue growth rate?

Revenue growth data for FPMI is available on our dashboard with detailed financial statement analysis.

Profitability metrics for FPMI are available on our dashboard with complete income statement analysis.

What are the risks of investing in FPMI?

Key risks for FPMI include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does FPMI compare to its competitors?

Compare FPMI to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize FPMI's performance and positioning.

What is FPMI's stock price target for 2026?

Our AI model provides price targets for FPMI based on fundamental analysis: Bull case $0.00 (+30%), Base case $0.00 (+15%), Bear case $0.00 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about FPMI?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for FPMI. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is FPMI's next earnings report?

FPMI reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

FPMI - Fluoropharma Medical

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About Fluoropharma Medical

FluoroPharma Medical, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with initial applications in the area of cardiology in the United States. The company was founded in 2003 and is headquartered in Montclair, New Jersey.

FPMI Key Statistics

Market Cap

$0.01M

P/B Ratio

17.76

Employees

How FPMI Compares to Peers

FPMI is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

N/A

of 5

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
FPMI(This stock)	$6.85K	N/A	0%	0.0%	-
AMGNAmgen Inc	$188.34B	24.6	0%	0.2%	vs AMGN
GILDGilead Sciences	$171.97B	20.4	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$110.81B	28.4	0%	0.3%	vs VRTX
REGNRegeneron Pharmaceuticals	$78.87B	18.0	0%	0.3%	vs REGN
BIIBBiogen Inc	$26.03B	20.0	-0%	0.1%	vs BIIB

Fluoropharma Medical Company Information

Headquarters: 8 Hillside Avenue, Montclair, NJ, United States, 07042, undefined
Website: www.fluoropharma.com
Sector: Healthcare
Industry: Biotechnology

Data Updated: April 18, 2026 at 2:43 PM EDT

Ready to invest in FPMI?

Commission-free trading available. Affiliate links.

Upcoming Events for FPMI

Dashboard

Enter a ticker to analyze